IGC Pharma, Inc.
IGC- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001326205
No open-market purchases or sales by IGC Pharma, Inc. insiders were filed in the last 90 days; 36 institutions reported holding it in 13F filings for Q2 2026, worth $1.41M in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding IGC Pharma, Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 23 | 30 | +7 |
| Shares | 2.80M | 2.84M | +37.5K (+1.3%) |
| Value | $1.19M | $954.3K | −$239.1K (−20.0%) |
New holders (9)
Institutions that held IGC Pharma, Inc. at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Squarepoint Ops LLC | 125,966 | $42.3K | 0.00% |
| HRT Financial LP | 27,737 | $9.00K | 0.00% |
| Jane Street Group, LLC | 16,760 | $5.63K | 0.00% |
| UBS Group AG | 3,118 | $1.05K | 0.00% |
| Citadel Advisors LLC | 3,068 | $1.03K | 0.00% |
| Hurley Capital, LLC | 100 | $36 | 0.00% |
| FMR LLC | 42 | $14 | 0.00% |
| Evermay Wealth Management LLC | 30 | $11 | 0.00% |
| GWM Advisors LLC | 14 | $5 | 0.00% |
Sold out (2)
Institutions that held IGC Pharma, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| Fullcircle Wealth LLC | 103,443 | $41.9K |
| Baader Bank INC | 10,533 | $3.17K |